Sirna Therapeutics' Unattributed VC Round

Sirna Therapeutics raised a round of funding on April 02, 2003. Investors include GGV Capital.

Sirna Therapeutics develops treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease.…

Articles about Sirna Therapeutics' Unattributed VC Round: